| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.23B | +7.5% |
| Cost of Revenue | $6.42B | +8.8% |
| Gross Profit | $2.80B | +4.5% |
| R&D Expense | $657.4M | -3.8% |
| SG&A Expense | $1.14B | -8.0% |
| Operating Income | -$713.8M | -1568.7% |
| Interest Expense | $588.9M | +4.9% |
| Pre-tax Income | -$1.30B | -143.2% |
| Income Tax | -$13.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $398.1M | +10.5% |
| Accounts Receivable | $1.52B | -0.6% |
| Inventory | $1.59B | +10.6% |
| Current Assets | $3.73B | +4.1% |
| Total Assets | $11.69B | -11.9% |
| Current Liabilities | $2.11B | -3.4% |
| Long-term Debt | $9.47B | -0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $190.0M | +55.4% |
| Capital Expenditures | $101.3M | -22.9% |
| Investing Cash Flow | -$82.1M | +40.0% |
| Financing Cash Flow | -$65.0M | +53.4% |
| Free Cash Flow | $88.7M | +1074.7% |
| +81.8% |
| Net Income | -$1.29B | -178.2% |
| EPS (Basic) | -$6.49 | -154.5% |
| EPS (Diluted) | -$6.49 | -154.5% |
| Total Liabilities |
| $12.13B |
| -1.9% |
| Stockholders' Equity | -$1.55B | -887.2% |